Identity
- Security key
- 18205
- Ticker
- LSTA
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 1999-03-01
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- LSTA
Detail
Enriched 2026-08-14 20:47
- Market cap
- $10,632,905.66
- Shares outstanding (class)
- 9,010,937
- Shares outstanding (weighted)
- 9,010,937
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 21
- Location
- BASKING RIDGE, NJ
- Homepage
- https://www.lisata.com
- Description
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.